We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$187B
AUM Growth
-$1.41B
Cap. Flow
-$15.2B
Cap. Flow %
-8.15%
Top 10 Hldgs %
24.38%
Holding
10,185
New
1,269
Increased
3,519
Reduced
3,507
Closed
1,718

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$940M
2
GLD icon
SPDR Gold Trust
GLD
+$375M
3
C icon
Citigroup
C
+$202M
4
GILD icon
Gilead Sciences
GILD
+$150M
5
M icon
Macy's
M
+$81.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.93%
2 Technology 1.75%
3 Financials 1.43%
4 Consumer Discretionary 0.87%
5 Healthcare 0.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SR icon
3926
Spire
SR
$4.88B
$1.62M ﹤0.01%
22,905
-40,973
-64% -$2.69M
DAR icon
3927
Darling Ingredients
DAR
$10.1B
$1.62M ﹤0.01%
108,882
-33,211
-23% -$480K
VUSE icon
3928
Vident US Equity Strategy ETF
VUSE
$693M
$1.62M ﹤0.01%
+64,504
New +$1.62M
WAIR
3929
PUT
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$1.62M ﹤0.01%
120,900
-1,700
-1% -$24.2K
ARIA
3930
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.62M ﹤0.01%
219,400
+600
+0.3% +$4.5K
KERX
3931
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.62M ﹤0.01%
244,600
+1,400
+0.6% +$7.83K
CSL icon
3932
Carlisle Companies
CSL
$14.2B
$1.62M ﹤0.01%
15,300
-3,123
-17% -$317K
CBSH icon
3933
Commerce Bancshares
CBSH
$8.32B
$1.62M ﹤0.01%
54,943
-10,091
-16% -$291K
TWM icon
3934
ProShares UltraShort Russell2000
TWM
$45.2M
$1.62M ﹤0.01%
+2,319
New +$1.71M
COHR
3935
CALL
DELISTED
Coherent Inc
COHR
$1.61M ﹤0.01%
17,600
+13,500
+329% +$1.24M
SCIJ
3936
DELISTED
Global X Scientific Beta Japan ETF
SCIJ
$1.61M ﹤0.01%
63,273
-2,596
-4% -$66K
IYE icon
3937
iShares US Energy ETF
IYE
$1.83B
$1.61M ﹤0.01%
42,086
+33,396
+384% +$1.24M
DES icon
3938
PUT
WisdomTree US SmallCap Dividend Fund
DES
$2.2B
$1.61M ﹤0.01%
67,500
+30,600
+83% +$710K
INTF icon
3939
iShares International Equity Factor ETF
INTF
$3.75B
$1.61M ﹤0.01%
72,178
+27,700
+62% +$644K
MXL icon
3940
MaxLinear
MXL
$5.6B
$1.61M ﹤0.01%
89,650
-29,977
-25% -$556K
SKOR icon
3941
Northern Trust Credit-Scored US Corporate Bond ETF
SKOR
$738M
$1.61M ﹤0.01%
+31,004
New +$1.6M
EVHC
3942
CALL
DELISTED
Envision Healthcare Holdings Inc
EVHC
$1.61M ﹤0.01%
21,209
-16,633
-44% -$1.18M
COL
3943
CALL
DELISTED
Rockwell Collins
COL
$1.61M ﹤0.01%
18,900
-29,000
-61% -$2.59M
AVY icon
3944
CALL
Avery Dennison
AVY
$13.5B
$1.61M ﹤0.01%
21,500
-17,800
-45% -$1.32M
IHE icon
3945
iShares US Pharmaceuticals ETF
IHE
$1.69B
$1.61M ﹤0.01%
33,366
-84,579
-72% -$4.02M
JPXN
3946
iShares JPX-Nikkei 400 ETF
JPXN
$139M
$1.61M ﹤0.01%
31,992
-15,449
-33% -$782K
ARR
3947
CALL
Armour Residential REIT
ARR
$2.31B
$1.6M ﹤0.01%
16,040
+1,740
+12% +$176K
GLCN
3948
DELISTED
VanEck China Growth Leaders ETF
GLCN
$1.6M ﹤0.01%
43,303
+37,600
+659% +$1.4M
SWIR
3949
DELISTED
Sierra Wireless
SWIR
$1.6M ﹤0.01%
94,571
+27,444
+41% +$474K
CVA
3950
CALL
DELISTED
Covanta Holding Corporation
CVA
$1.6M ﹤0.01%
97,500
+86,800
+811% +$1.43M

Similar funds

Jeff Yass's Q2 2016 Portfolio in Review

As of Q2 2016, Jeff Yass held 10,185 positions worth $187B, down 0.75% from $188B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass withdrew a net $15.2B in Q2 2016, closing 1,718 positions and reducing 3,507 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $700M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 90% a quarter earlier, followed by Technology and Financials.

Against the trend, Jeff Yass opened a new position in Vanguard Long-Term Bond ETF worth $47.5M.

  • Jeff Yass's largest Q2 2016 buy was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M.
  • Jeff Yass added most to Apple in Q2 2016, an estimated $940M increase.
  • Jeff Yass's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.28B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ETF in Q2 2016, selling an estimated $700M.
  • Jeff Yass's ten largest holdings make up 24% of its $187B portfolio in Q2 2016.
  • Jeff Yass opened 1,269 new positions and closed 1,718 in Q2 2016.
  • Jeff Yass's portfolio value fell 0.75% quarter-over-quarter to $187B.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.